Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for borderline personality disorder
IRCT20210106049948N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of memantine in borderline personality disorder (BPD), sponsored by Iran University of Medical Sciences. Started Apr 2021; status: completed.
02
Drugs
memantine
03
Conditions
borderline personality disorder (BPD)
Beyond the preview
Go deeper on IRCT20210106049948N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210106049948N1.